Skip to main content
Clinical Trials/ACTRN12619000099123
ACTRN12619000099123Not yet recruiting未知

Examining the effect of creatine supplementation in augmenting adaptations to resistance training in prostate cancer patients undergoing androgen deprivation therapy: a randomized, double-blind, placebo controlled trial.

Edith Cowan University0 sites56 target enrollmentStarted: January 23, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
56

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
Male

Inclusion Criteria

  • Men with localised or locally advanced prostate cancer, who are currently on ADT (and expected to remain on ADT for the next three months) will be eligible to enrol in this study.

Exclusion Criteria

  • Participants will be excluded if they have any visceral or bone metastases (i.e. advanced, or castrate-resistant prostate cancer); are being treated for any secondary or other cancers.

Investigators

Similar Trials